Data / Form D filings / HYPERION DEFI, INC.
HYPERION DEFI, INC.: Form D filings
HYPERION DEFI, INC., a pharmaceuticals company in Laguna Hills, CA, filed 4 Form D notices with the SEC between 2016 and 2025. The latest, on July 22, 2025, reports $50 million sold of a $50 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 23461 SOUTH POINTE DRIVE, SUITE 390, Laguna Hills, CA, 92653
- Phone
- (833) 393-6684
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1682639
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 22, 2025 | New notice | $49,999,999 | $49,999,999 | 5 | Jun 20, 2025 | sec.gov | |
| Apr 7, 2020 | New notice | $5,985,000 | $5,985,000 | 82 | Mar 24, 2020 | sec.gov | |
| Aug 14, 2017 | New notice | $20,000,000 | $6,000,000 | $14,000,000 | 10 | Jul 7, 2017 | sec.gov |
| Aug 24, 2016 | New notice | $8,000,000 | $4,041,337 | $3,958,663 | 4 | Jul 19, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Geltzeiler | Director | |
| Michael Rowe | Executive Officer, Director | |
| Rachel Jacobson | Director | |
| Hyunsu Jung | Executive Officer, Director | |
| Ellen Strahlman | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jul 21, 2025 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what HYPERION DEFI, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.